IL17A and psoriasis: Moreover, these patients showed a positive correlation between Th17/Treg cell ratio in the skin and disease activity, together with a decrease in the frequency and suppressive activity of Tregs [32], and anti-IL-17 antibody treatment conferred excellent therapeutic responses in patients with psoriasis [33].